About 5 400 reports

  • ANTI-CANCER MABS ACT AGAINST MALIGNANT CELLS THROUGH THE MECHANISMS MENTIONED IN THE EXHIBIT BELOW.
  • AMGEN: GEOGRAPHIC SEGMENTATION OF XGEVA 2015

Factors such as the rise in the number of companies venturing into monoclonal antibodies space and the introduction of low cost biosimilar monoclonal antibodies, will provide considerable growth opportunities to monoclonal antibodies manufactures

  • Medical Biotechnology
  • Pharmaceutical
  • Therapy
  • World
  • Market Size

Development of CD## bispecific antibodies The bispecific antibodies are a combination of two or more antigens into a single product and can bind two or more specific targets, more than one pathway at the target disease.

  • Medical Biotechnology
  • Pharmaceutical
  • Therapy
  • World
  • Market Segment
  • IV. MONOCLONAL ANTIBODY PRODUCTION AND
  • IV. MONOCLONAL ANTIBODY PRODUCTION AND

Autoimmunity Diseases Treatment Antibody is one important Monoclonal Antibody in China.

  • Pharmaceutical
  • China
  • Beijing Biotech Pharmaceutical Co., Ltd.
  • Beijing Tiantan Biological Products Co., Ltd.
  • Shanghai CP Guojian Pharmaceutical Co., Ltd.

EXECUTIVE SUMMARY ##.

  • Medical Biotechnology
  • Pharmaceutical
  • APAC
  • Demand
  • Market Shares
  • Monoclonal Antibody Companies in China
  • Monoclonal Antibody Production

Autoimmunity Diseases Treatment Antibody is one important Monoclonal Antibody in China.

  • Pharmaceutical
  • China
  • Beijing Biotech Pharmaceutical Co., Ltd.
  • Roche Group
  • Shanghai CP Guojian Pharmaceutical Co., Ltd.
  • IV. MONOCLONAL ANTIBODY PRODUCTION AND
  • Monoclonal Antibody Imports

INTRODUCTION Chapter I Table ##: Economic Outlook Summary (Billion Yuan) Chart ##: Economic Outlook Summary (Billion Yuan) Chapter I INTRODUCTION The current market for Monoclonal Antibody in China is growing rapidly.

  • Pharmaceutical
  • Targeted Therapy
  • China
  • Beijing Biotech Pharmaceutical Co., Ltd.
  • Shanghai CP Guojian Pharmaceutical Co., Ltd.

Global Monoclonal Antibody Partnering Terms and Agreements 2014 to 2019 Chapter ## – Introduction Chapter ## – Trends in monoclonal antibody dealmaking ##. ##.

  • Medical Biotechnology
  • Monoclonal Antibody
  • Pharmaceutical
  • United States
  • Demand

Global and China Monoclonal Antibody Industry Report, 2019-2025 ##.

  • Medical Biotechnology
  • Monoclonal Antibody
  • Pharmaceutical
  • China
  • Market Size

Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2014-2019: Deal trends, players and financials Executive Summary Chapter ## – Introduction Chapter ## – Trends in Cancer monoclonal antibody dealmaking ##. ##.

  • Cancer
  • Monoclonal Antibody
  • Pharmaceutical
  • United States
  • Demand

GLOBAL BIOSIMILAR MONOCLONAL ANTIBODIES FORECAST 2018-2028 ##.

  • Medical Biotechnology
  • Pharmaceutical
  • World
  • Market Shares
  • Market Size

The 2020-2025 World Outlook for Monoclonal Antibody (MAb)-Based Products ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Medical Biotechnology
  • Pharmaceutical
  • Therapy
  • World
  • Demand

The 2020-2025 World Outlook for Biosimilar Monoclonal Antibodies (mAb) ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Medical Biotechnology
  • Pharmaceutical
  • Therapy
  • World
  • Demand

The 2020-2025 World Outlook for Gastric Cancer Monoclonal Antibodies (mAb) ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Medical Biotechnology
  • Pharmaceutical
  • Therapy
  • World
  • Demand

The 2020-2025 World Outlook for Colorectal Cancer Monoclonal Antibodies (mAb) ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Medical Biotechnology
  • Pharmaceutical
  • Therapy
  • World
  • Demand

The 2020-2025 World Outlook for Rheumatoid Arthritis (RA) Monoclonal Antibodies (mAb) ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Medical Biotechnology
  • Pharmaceutical
  • Therapy
  • World
  • Demand

The 2020-2025 World Outlook for Esophageal Cancer Monoclonal Antibodies (mAb) ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Medical Biotechnology
  • Pharmaceutical
  • Therapy
  • World
  • Demand

The 2020-2025 World Outlook for Breast Cancer Monoclonal Antibodies (mAb) ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Medical Biotechnology
  • Pharmaceutical
  • Therapy
  • World
  • Demand

Monoclonal Antibody Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025 ##.

  • Pharmaceutical
  • Therapy
  • World
  • Market Size

Global Cancer Monoclonal Antibodies Market & Clinical Trial Insight 2024 ##.

  • Medical Biotechnology
  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • World

Biosimilar Monoclonal Antibodies Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024 ##.

  • Medical Biotechnology
  • Monoclonal Antibody
  • Pharmaceutical
  • World
  • Market Size
  • HIGHLIGHTS

Ado-trastuzumab emtansine (Kadcyla, ), an antibody that targets HER##, attaches itself to a chemo drug called Myotonic dystrophy type ## (DM##).

  • Pharmaceutical
  • Amgen Inc.
  • Biocon Limited
  • Mylan Inc.
  • Roche Group
  • VERSATILITY OF PIPELINE PRODUCTS ACROSS THERAPY AREAS, INDICATIONS AND TARGETS
  • 8.2 REFERENCES

Immunotoxicity of monoclonal antibodies. mAbs; ##(##): ##-## Duan C, et al. (2015).

  • Pharmaceutical
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Genentech, Inc.
  • Johnson & Johnson

The Development of Therapeutic Monoclonal Antibody Products CHAPTER ##: The Therapeutic Monoclonal Antibody Market ## CHAPTER ##: Overview of Chemistry, Manufacturing, and Control Activities for Monoclonal Antibody Product Developm

  • Biopharmaceutical
  • Medical Biotechnology
  • Monoclonal Antibody
  • Pharmaceutical
  • Demand

Monoclonal Antibody Therapeutics Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2016 - 2024 ##.

  • Monoclonal Antibody
  • Pharmaceutical
  • APAC
  • World
  • Market Size
  • SCOPE OF THE REPORT
  • KEY NEWS

ADCETRIS is a chimeric monoclonal immunoglobulin (Ig)G## antibody, which acts against CD## expressed in HL and systemic anaplastic large cell lymphoma.

  • Pharmaceutical
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited
  • MONOCLONAL ANTIBODY THERAPEUTICS MARKET GROWTH, 2015- 2020
  • NORTH AMERICA: CHROMATOGRAPHY RESIN MARKET SIZE, BY COUNTRY, 2017-2024 (LITER)

Australia has been focusing on monoclonal antibody production.

  • Pharmaceutical
  • GE Healthcare Limited
  • Merck & Co., Inc.
  • Repligen Corporation
  • Tosoh Corporation

Patent expiry of several blockbuster monoclonal antibodies in the near future, is another major factor supporting the growth of the antibody production market.

  • Immunotherapy
  • Medical Biotechnology
  • Pharmaceutical
  • United States
  • Supply
  • Monoclonal Antibody
  • SRK-015

Figure ##: Overview of the Development Pipeline in SMA Monoclonal Antibody Fast Skeletal Muscle Troponin Activator SRK-## Figure ##: Key Trials for the Promising Pipeline Agents that GlobalData Expects to Be Licensed for © GlobalData TABLE ## PROVIDES THE COMPARISON OF DIFFERENT TH

  • Neurological Disorder
  • Pharmaceutical
  • United States
  • World
  • Forecast
  • Monoclonal Antibody
  • Monoclonal Antibody

Hoffmann-La Roche Ltd Monoclonal Antibody 2016 Fourth ## Siliq brodalumab AstraZeneca Plc Monoclonal Antibody 2016 Fourth ## Zinplava bezlotoxumab Merck & Co Inc Monoclonal Antibody 2016 Fourth - Lartruvo olaratumab Eli Lilly and Co

  • Pharmaceutical
  • AbbVie Inc.
  • Alexion Pharmaceuticals, Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • MONOCLONAL ANTIBODIES (MABS)
  • Global Monoclonal Antibodies Market, 2017, By Source

METABOLIC MONOCLONAL ANTIBODIES THIRD ONE?

  • Pharmaceutical
  • Market Size
  • AbbVie Inc.
  • Pfizer Inc.
  • Sanofi S.A.